Global mammography market was worth USD 1.8 billion in 2020. It is projected to grow at a compound annual rate of 10.0% between 2021 and 2028. The key factors expected to drive breast cancer diagnostic device demand over the forecast period include the rising incidence of breast cancer and the increasing demand for early-stage diagnosis among patients. Market growth is expected to be driven by increased access to breast-cancer screening systems and government initiatives to assist with clinical interpretation. The Health Resources and Services Administration (HRSA), for instance, has created a healthcare program that will increase screening in areas where there is less access to them.
The COVID-19 pandemic led to significant reductions in cancer screening, management visits and procedures around the world. A study was done in the U.K. to examine the effects of COVID-19 on delayed cancer detection. It was published in The Lancet Oncology, March 2021. The study included data from more than 100,000 people suffering from colorectal, esophageal or lung cancer. Due to the inaccessibility of screening services, the study showed that the 1- and 5-year survival rates for cancer will be significantly reduced. Because of lockdowns, some screening services have been disrupted which could lower demand for mammography systems. Numerous physician reports from the U.S. indicate that screening appointments have increased in the past quarter of 2020 and are expected to continue rising to pre-covid levels by 2021.
One of the main factors driving the rise in breast cancer incidence around the world is mammography. According to WHO, around 627,000 women were killed by breast cancer worldwide in 2018. It is also estimated that breast cancer rates are higher in women living in developed countries than in developing ones. According to Cancer Organization India in 2018, 25.0% of all cancer cases among women was caused by breast and oral cavity cancer. According to Susan G Komen Breast Cancer Foundation, Inc., around 41,760 women will die from breast cancer in 2019. According to South African Journal of Radiology in 2018, breast cancer was the leading cause of death in South Africa.
New products are expected to increase the adoption rate of end-users. The older generations of mammography systems only provided 2D images, which limited the quality of interpretation. 2D mammography systems can provide Craniocaudal and Mediolateral Oblique (MLO), images. Because of the calcifications and tissue overlapping, these images are difficult to interpret and can make it difficult for doctors to identify cancerous lesions. Digital Breast Tomosynthesis (DBT) is a 3D-based technology that allows for the capture of a 3D image. This allows radiologists to scan each breast slice by slice, and find abnormalities that would otherwise be hidden in 2D images.
The mammography market was dominated by the digital systems segment, which accounted for the largest share of revenue at 61.6% in 2020. It is expected to continue growing over the forecast period. The market is expected to grow due to rising demand for technologically enhanced breast cancer screening systems. With a CAGR rate of 11.9%, the 3D system will be the fastest growing segment. The surge in demand for 3D systems was caused by government-issued Acts like the Medical Imaging Modernization Act 2015, which was ordained to encourage technological advances.
The fastest-growing segment in the forecast is the 3D systems segment. There are many advantages to switching to 3D systems for hospitals and diagnostic clinics. 2D systems can often fail to detect every sign of cancer. This leads to increased diagnostic costs. Hologic, one of the leading 3D system companies, has begun to market their products directly.
The digital mammography segment was the dominant market in 2020 and accounted for more than 67.0% of the total revenue share. This is due to its many advantages. The adoption and use of digital mammography will be enhanced by technological advancements in breast cancer screening devices. Over the forecast period, the breast tomosynthesis segment will experience the most rapid growth.
The segment is also driven by huge commercial availability and growing demand among healthcare professionals for mammography technology. Siemens Healthcare Private Limited (GE Healthcare) and General Electric Company are the two major players in this market. These devices were first introduced with digital technology in 1996 as a prototype technology. It has now become a mature market segment as of 2015.
North America was the dominant market, accounting for 37.2% of the total revenue in 2020. Over the forecast period, North America is expected to experience a significant growth rate. Market growth is driven by the rising incidence of breast Cancer. The market will be driven by the development of healthcare infrastructure and rising healthcare spending over the forecast period.
The market in Asia Pacific is expected to experience the fastest growth during the forecast period. Market growth is expected to be boosted by the presence of developing countries like Japan and China. Key players continue to make efforts to gain access to emerging markets in Asia Pacific. This is expected to increase the market's growth over the forecast period.
Hologic offers a broad product range, including breast tomosynthesis technology and digital mammography. To maintain their market position in mammography, key players are involved in numerous strategic initiatives. Hologic Inc. is a developer, producer and provider of high quality diagnostics, surgical imaging devices. In December 2020, Hologic Inc. announced U.S. FDA approval for its Genius AI Detection software, a deep learning-based program that aids radiologists in detecting subtle cancers in breast tomosynthesis photos. The market leader in mammography is:
Hologic
Fujifilm
Siemens Healthcare
Phillips Healthcare
Toshiba Medical Systems
GE Healthcare
Metaltronica
I.M.S. Srl
Up Market Research published a new report titled “Mammography Market research report which is segmented by Product (Digital Systems, Biopsy Systems, 3D Systems, Analog Systems, Film Screen Systems), By Players/Companies IMS Srl, GE Healthcare, Siemens Healthcare, Fujifilm, Hologic, Phillips Healthcare, Metaltronica, Toshiba Medical Systems”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Mammography Market Research Report |
By Product | Digital Systems, Biopsy Systems, 3D Systems, Analog Systems, Film Screen Systems |
By Companies | IMS Srl, GE Healthcare, Siemens Healthcare, Fujifilm, Hologic, Phillips Healthcare, Metaltronica, Toshiba Medical Systems |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 248 |
Number of Tables & Figures | 174 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Product (Digital Systems, Biopsy Systems, 3D Systems, Analog Systems, Film Screen Systems).
Mammography Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Mammography Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Mammography Market Report:
Some other reports from this category!